Vivamed Sp. z o.o.

At Vivamed Sp. z o.o. in Warsaw, investigators are concentrating on inflammatory bowel conditions, seeking to improve outcomes for patients with moderately to severely active ulcerative colitis and Crohn's disease.

• Combination therapy with biologic agents
• Evaluation of new oral small‑molecule treatments
• Clinical remission assessment using standardized scores

These efforts integrate gastroenterology expertise with innovative therapeutic strategies to enhance patient quality of life.

The clinical program explores immune‑mediated pathways that drive bowel inflammation, testing novel methods to modulate the immune response in severe disease.

• Targeting interleukin signaling pathways
• Dual‑target biologic regimens
• Placebo‑controlled studies of remission rates

The goal is to expand therapeutic options for patients whose disease remains active despite conventional treatments.